Skip to main content

Advertisement

Log in

Mood, Meth, Condom Use, and Gender: Latent Growth Curve Modeling Results from a Randomized Trial

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Methamphetamine use poses increased risk for HIV and other sexually transmitted infections. There is robust evidence that methamphetamine use increases sexual risk behavior, like condomless sex, primarily among men who have sex with men but also among heterosexual women and men. Gender differences have been found among women and men who use meth, and there is a high degree of interconnectedness between meth use, depression, and condomless sex. The aims of the current study are to evaluate the efficacy of a theory-based, tri-focal intervention designed to reduce depression, meth use, and condomless sex among women and men, and to examine gender as a moderator of efficacy. A total of 432 HIV-negative women and men who use meth participated in a two-arm randomized controlled trial and completed baseline and follow-up assessments at 4, 8, and 12 months. We used latent growth curve modeling techniques to analyze the data. Results showed that while all participants exhibited reductions in depression, meth use, and condomless sex, the intervention and comparison groups did not differ in changes over time. However, we did find a significant gender moderation effect, such that among men, those in the intervention arm reported greater reductions in meth use relative to those in the comparison group; reduced meth use was associated with reduced condomless sex, but not depression. In contrast, women in the intervention condition did not differ from women in the comparison condition in changes in any of the three outcome variables. Interventions targeting heterosexual women and men who use meth must be gender-specific, and take into account the unique vulnerabilities and experiences of women, including the perceived positive aspects of using meth, gendered power dynamics, higher depression, and violence.

Resumen

El uso de metanfetaminas incrementa el riesgo de VIH y otras enfermedades de transmisión sexual. Existe evidencia robusta que el uso de metanfetaminas incrementa las conductas sexuales de riesgo, como las relaciones sexuales sin condón, principalmente entre los hombres que tienen sexo con hombres, pero también entre las mujeres y hombres heterosexuales. Se han encontrado diferencias de géneros entre los las mujeres y hombres que usan metanfetaminas, y existe un alto grado de interconexión entre el uso de metanfetaminas, la depresión, y las relaciones sexuales sin condón. Los objetivos del presente estudio son: 1) Evaluar la eficacia de una intervención tri-focal basada en teoría diseñada para reducir la depresión, el uso de metanfetaminas, y las relaciones sexuales sin condón entre mujeres y hombres, y 2) examinar el género como un moderador de la eficacia. Un total de 432 mujeres y hombres sin VIH que utilizan metanfetaminas participaron en un ensayo aleatorizado controlado de dos brazos y completaron evaluaciones al inicio del estudio y a las 4, 8, y 12 meses. Utilizamos un modelo de curvas latentes de crecimiento para analizar los datos. Los resultados demostraron que mientras todos los participantes exhibieron reducciones en la depresión, uso de metanfetaminas, y relaciones sexuales sin condón, no hubo cambios a través del tiempo entre el grupo de intervención y el de comparación. Sin embargo, encontramos un efecto de moderación de género significativa, tal que los hombres en el grupo de intervención reportaron una reducción mayor en el uso de metanfetaminas relativa a los hombres en el grupo de comparación; la reducción en el uso de metanfetaminas estuvo asociado con la reducción de las relaciones sexuales sin condón, pero no de la depresión. En contraste, no hubo diferencia entre las mujeres en el grupo de intervención y el grupo de comparación en alguna de las variables dependientes. Las intervenciones enfocadas a las mujeres y hombres heterosexuales que utilizan metanfetaminas deben de ser especificas de género, tomando en cuenta las vulnerabilidades y experiencias únicas de las mujeres, incluyendo las percepciones positivas del uso de metanfetaminas, dinámicas de poder entre géneros, niveles mayores de depresión, y violencia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep. 2005;2(4):194–9.

    Article  PubMed  Google Scholar 

  2. Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission. J Homosex. 2001;41(2):17–35.

    Article  PubMed  CAS  Google Scholar 

  3. Chesney MA, Barrett DC, Stall R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health. 1998;88(1):113–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Cohen J. Life in the fast lane: HIV and Meth. Science. 2012;337(6091):176–7.

    Article  PubMed  Google Scholar 

  5. Plankey MW, Ostrow DG, Stall R, Cox C, Li X, Peck JA, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2007;45(1):85–92.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Semple SJ, Zians J, Strathdee SA, Patterson TL. Sexual marathons and methamphetamine use among HIV-positive men who have sex with men. Arch Sex Behav. 2009;38(4):583.

    Article  PubMed  Google Scholar 

  7. Stone E, Heagerty P, Vittinghoff E, Douglas JM, Koblin BA, Mayer KH, et al. Correlates of condom failure in a sexually active cohort of men who have sex with men. JAIDS J Acquir Immune Defic Syndr. 1999;20(5):495–501.

    Article  CAS  Google Scholar 

  8. Mausbach BT, Semple SJ, Strathdee SA, Zians J, Patterson TL. Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study. Drug Alcohol Depend. 2007;87(2):249–57.

    Article  PubMed  Google Scholar 

  9. Reback CJ, Grant DL, Fletcher JB, Branson CM, Shoptaw S, Bowers JR, et al. Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men. AIDS Behav. 2012;16(7):1993–2002.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Shoptaw S, Reback CJ. Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. J Urban Health. 2006;83(6):1151–7.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Shoptaw S, Reback CJ. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction. 2007;102(s1):130–5.

    Article  PubMed  Google Scholar 

  12. Corsi KF, Booth RE. HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present. Curr Drug Abuse Rev. 2008;1(3):292–6.

    Article  PubMed  Google Scholar 

  13. Hittner JB. Meta-analysis of the association between methamphetamine use and high-risk sexual behavior among heterosexuals. Psychol Addict Behav. 2016;30(2):147–57.

    Article  PubMed  Google Scholar 

  14. Molitor F, Truax SR, Ruiz JD, Sun RK. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med. 1998;168(2):93–7.

    PubMed  PubMed Central  CAS  Google Scholar 

  15. Melis MR, Argiolas A. Dopamine and sexual behavior. Neurosci Biobehav Rev. 1995;19(1):19–38.

    Article  PubMed  CAS  Google Scholar 

  16. Semple SJ, Grant I, Patterson TL. Female methamphetamine users: social characteristics and sexual risk behavior. Women Health. 2004;40(3):35–50.

    Article  PubMed  Google Scholar 

  17. Lorvick J, Bourgois P, Wenger LD, Arreola SG, Lutnick A, Wechsberg WM, et al. Sexual pleasure and sexual risk among women who use methamphetamine: a mixed methods study. Int J Drug Policy. 2012;23(5):385–92.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Maher L, Phlong P, Mooney-Somers J, Keo S, Stein E, Couture MC, et al. Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Int J Drug Policy. 2011;22(3):203–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Brecht M-L, O’Brien A, Von Mayrhauser C, Anglin MD. Methamphetamine use behaviors and gender differences. Addict Behav. 2004;29(1):89–106.

    Article  PubMed  Google Scholar 

  20. Lorvick J, Martinez A, Gee L, Kral AH. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health. 2006;83(3):497–505.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Mausbach BT, Semple SJ, Zians J, Patterson TL, Strathdee SA. Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-negative, heterosexual methamphetamine users: results from the fast-lane study. Ann Behav Med. 2007;34(3):263–74.

    Article  PubMed  Google Scholar 

  22. Mimiaga MJ, Reisner SL, Pantalone DW, O’Cleirigh C, Mayer KH, Safren SA. A pilot trial of integrated behavioral activation and sexual risk reduction counseling for HIV-uninfected men who have sex with men abusing crystal methamphetamine. AIDS Patient Care STDs. 2012;26(11):681–93.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend. 2005;78(2):125–34.

    Article  PubMed  Google Scholar 

  24. Jaffe A, Shoptaw S, Stein JA, Reback CJ, Rotheram-Fuller E. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. Exp Clin Psychopharmacol. 2007;15(3):301–7.

    Article  PubMed  Google Scholar 

  25. Reback CJ, Larkins S, Shoptaw S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav. 2004;8(1):87–98.

    Article  PubMed  Google Scholar 

  26. Pitpitan EV, Semple SJ, Zians J, Strathdee SA, Patterson TL. Cognitive behavioral therapy for HIV-negative heterosexual meth users: the FASTLANE II intervention. Cogn Behav Pract. 2014;21(2):176–90.

    Article  Google Scholar 

  27. Beck JS. Cognitive-behavioral therapy. Prim Psychiatr. 2006;13(4):31–4.

    Google Scholar 

  28. Bandura A. Social cognitive theory: an agentic perspective. Annu Rev Psychol. 2001;52(1):1–26.

    Article  PubMed  CAS  Google Scholar 

  29. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior, vol. 278. New Jersey: Prentice-Hall; 1980.

    Google Scholar 

  30. Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. [Internet]. Guilford press; 1991. http://psycnet.apa.org/psycinfo/1991-98398-000. Accessed 27 Sep 2013.

  31. Conigrave KM, Hall WD, Saunders JB. The AUDIT questionnaire: choosing a cut-off score. Addiction. 1995;90(10):1349–56.

    Article  PubMed  CAS  Google Scholar 

  32. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addict Abingdon Engl. 1993;88(6):791–804.

    Article  CAS  Google Scholar 

  33. Beck AT, Steer RA, Brown GK. Manual for the BDI-II. San Antonio, TX: Psychological Corporation; 1996.

    Google Scholar 

  34. Wang J, Siegal HA, Falck RS, Carlson RG, Rahman A. Evaluation of HIV risk reduction intervention programs via latent growth model. Eval Rev. 1999;23(6):648–62.

    Article  PubMed  CAS  Google Scholar 

  35. Roesch SC, Norman GJ, Adams MA, Kerr J, Sallis JF, Ryan S, et al. Latent growth curve modeling of adolescent physical activity: testing parallel process and mediation models. J Health Psychol. 2009;14(2):313–25.

    Article  PubMed  Google Scholar 

  36. Beauchaine TP, Webster-Stratton C, Reid MJ. Mediators, moderators, and predictors of 1-year outcomes among children treated for early-onset conduct problems: a latent growth curve analysis. J Consult Clin Psychol. 2005;73(3):371.

    Article  PubMed  Google Scholar 

  37. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model Multidiscip J. 1999;6(1):1–55.

    Article  Google Scholar 

  38. Becker H, Roberts G, Voelmeck W. Explanations for improvement in both experimental and control groups. West J Nurs Res. 2003;25(6):746–55.

    Article  PubMed  Google Scholar 

  39. Capellan J, Wilde MH, Zhang F. Measurement reactivity in a randomized clinical trial using self-reported data. J Nurs Scholarsh. 2017;49(1):111–9.

    Article  PubMed  Google Scholar 

  40. Hundhammer T, Mussweiler T. How sex puts you in gendered shoes: sexuality-priming leads to gender-based self-perception and behavior. J Pers Soc Psychol. 2012;103(1):176–93.

    Article  PubMed  Google Scholar 

  41. Kiefer AK, Sanchez DT, Kalinka CJ, Ybarra O. How women’s nonconscious association of sex with submission relates to their subjective sexual arousability and ability to reach orgasm. Sex Roles. 2006;55(1–2):83–94.

    Article  Google Scholar 

  42. Rudman LA, Glick P. Prescriptive gender stereotypes and backlash toward agentic women. J Soc Issues. 2001;57:743–62.

    Article  Google Scholar 

  43. Sanchez DT, Kiefer AK, Ybarra O. Sexual submissiveness in women: costs for sexual autonomy and arousal. Pers Soc Psychol Bull. 2006;32(4):512–24.

    Article  PubMed  Google Scholar 

  44. Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet. 2004;363(9419):1415–21.

    Article  PubMed  Google Scholar 

  45. Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet. 2010;376(9734):41–8.

    Article  PubMed  Google Scholar 

  46. Tsuyuki K, Pitpitan EV, Levi-Minzi MA, Urada LA, Kurtz SP, Stockman JK, et al. Substance use disorders, violence, mental health, and HIV: differentiating a syndemic factor by gender and sexuality. AIDS Behav. 2017;21(8):2270–82.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Abdul-Khabir W, Hall T, Swanson A-N, Shoptaw S. Intimate partner violence and reproductive health among methamphetamine-using women in Los Angeles: a qualitative pilot study. J Psychoact Drugs. 2014;46(4):310–6.

    Article  Google Scholar 

  48. Stockman JK, Ludwig-Barron N, Hoffman MA, Ulibarri MD, Dyer TVP. Prevention interventions for human immunodeficiency virus in drug-using women with a history of partner violence. Subst Abuse Rehabil. 2012;3(Suppl 1):45–57.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Auerbach JD, Smith LR. Theoretical foundations of research focused on HIV prevention among substance-involved women: a review of observational and intervention studies. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S146–54.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Stockman JK, Syvertsen JL, Robertson AM, Ludwig-Barron NT, Bergmann JN, Palinkas LA. Women’s perspectives on female-initiated barrier methods for the prevention of HIV in the context of methamphetamine use and partner violence. Womens Health Issues. 2014;24(4):e397–405.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was funded by National Institute of Mental Health Grant R01MH061146. Preparation of this manuscript was supported by a Mentored Career Development Award from the National Institute on Drug Abuse to the first author (K01DA036447).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eileen V. Pitpitan.

Ethics declarations

Conflicts of interest

All authors have no conflicts of interest to declare.

Ethical Approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pitpitan, E.V., Semple, S.J., Zians, J. et al. Mood, Meth, Condom Use, and Gender: Latent Growth Curve Modeling Results from a Randomized Trial. AIDS Behav 22, 2815–2829 (2018). https://doi.org/10.1007/s10461-018-2147-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-018-2147-9

Keywords

Navigation